newsfilter
← Latest News
GlobeNewswire·

Agile Therapeutics Provides Updates on 2022 Twirla Performance and 2023 Commercial Plan

Fourth Quarter 2022 Twirla Factory Sales Expected to Increase Approximately 30% from Third Quarter 2022 Full Year 2022 Factory Sales Expected to Increase Approximately 232% from Full Year 2021 Full Year 2023 Net